1. Phase 3 Study of Fezolinetant for Treatment of Moderate-to-Severe Vasomotor Symptoms Associated With Menopause [A132]. (May 2022) Authors: Lederman, Samuel; Shapiro CM, Marla; Stute, Petra; Lee, Misun; Wang, Xuegong; Neal-Perry, Genevieve Journal: Obstetrics and gynecology Issue: Volume 139(2022)Supplement 1 Page Start: 39S Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗